Soleno Therapeutics (SLNO)
(Delayed Data from NSDQ)
$37.89 USD
+0.55 (1.47%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $37.84 -0.05 (-0.13%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth C Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/14/24 |
---|---|
Current Quarter | -0.30 |
EPS Last Quarter | -0.33 |
Last EPS Surprise | -6.45% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.23 |
Next Year | -0.92 |
EPS (TTM) | -2.97 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | 29.55M |
# of Estimates | NA | NA | NA | 3 |
High Estimate | NA | NA | NA | 36.70M |
Low Estimate | NA | NA | NA | 17.36M |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.30 | -0.29 | -1.23 | -0.92 |
# of Estimates | 3 | 3 | 4 | 3 |
Most Recent Consensus | NA | NA | -1.06 | NA |
High Estimate | -0.28 | -0.28 | -1.06 | -0.57 |
Low Estimate | -0.33 | -0.30 | -1.41 | -1.18 |
Year ago EPS | -0.88 | -0.81 | -2.36 | -1.23 |
Year over Year Growth Est. | 65.91% | 64.20% | 47.88% | 25.14% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 1 | 2 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 2 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.30 | -0.29 | -1.23 | -0.92 |
7 Days Ago | -0.30 | -0.29 | -1.23 | -0.92 |
30 Days Ago | -0.30 | -0.29 | -1.23 | -0.92 |
60 Days Ago | -0.27 | -0.27 | -1.21 | -0.88 |
90 Days Ago | -0.26 | -0.26 | -1.17 | 0.27 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.30 | -0.29 | -1.23 | -0.92 |
Zacks Consensus Estimate | -0.30 | -0.29 | -1.23 | -0.92 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.33 | -0.95 | -0.81 | -0.88 | NA |
Estimate | -0.31 | -0.62 | -0.70 | -0.71 | NA |
Difference | -0.02 | -0.33 | -0.11 | -0.17 | -0.16 |
Surprise | -6.45% | -53.23% | -15.71% | -23.94% | -24.83% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more